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Abstract
Despite China“s free antiretroviral treatment (ART) program, there are high rates of treatment
failure, large sociodemographic disparities in care outcomes and emerging medication resistance.
Understanding patient medication adherence behaviors and challenges could inform adherence
interventions to maximize the individual and prevention benefits of ART. This study assessed
recent non-adherence and treatment interruption among 813 HIV-infected adult outpatients in
Guangzhou, China. Participants completed a behavioral survey, underwent chart review, and were
tested for syphilis, gonorrhea, and chlamydia. Factors associated with suboptimal adherence were
identified using univariate and multivariate logistic regression. Among 721 HIV-infected adults
receiving ART, 18.9% reported recent non-adherence (any missed ART in the past 4 weeks) and
6.8% reported treatment interruption (four or more weeks of missed ART in the past year). Lower
education, living alone, alcohol use and being on ART one to three years were associated with
recent non-adherence. Male gender, lower education and being on ART one to three years were
associated with treatment interruption. ART medication adherence interventions are needed in
China that include individualized, long-term adherence plans sensitive to patients“ educational and
economic situations. These interventions should also consider possible gender disparities in
treatment outcomes and address the use of alcohol during ART. Successful ART medication
adherence interventions in China can inform other international settings that face similar
adherence challenges and disparities.
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The HIV Prevention Trials Network 052 generated renewed urgency to optimize patient
adherence to antiretroviral therapy (ART) in order to improve individual patient outcomes
and reduce forward HIV transmission (Cohen et al., 2011). China embraced HIV treatment
as prevention initiatives through its National Free Antiretroviral Treatment Program and a
2012 decision to promote earlier ART initiation (Zhao, Poundstone, Montaner, & Wu,
2012). Amidst rapid ART scale-up, poor medication adherence threatens these
initiatives“ ability to achieve virologic suppression (Zhang et al., 2009) and reverse
increasing medication resistance (Gardner, Burman, Steiner, Anderson, & Bangsberg, 2009)
documented in China (Liao et al., 2012) and globally (Gupta et al., 2012).
In 2011, 126,448 of China“s estimated 780,000 persons living with HIV were receiving free
ART (Ministry of Health People“s Republic of China, 2012), however wide disparities in
adherence and treatment outcomes have been noted (Xing et al., 2013; Yan et al., 2013;
Zhang et al., 2009). As ART expands, a better understanding of patient adherence is
urgently needed. This study assessed factors associated with suboptimal adherence among a
large sample of HIV-infected individuals in south China.
METHODS
The main study design has been reported in detail (X. B. Wang et al., 2012). Briefly,
between April and June 2011, 813 HIV-infected outpatients 18 years of age and older were
recruited at the largest HIV clinic in Guangzhou, China for a cross-sectional survey and
sexually transmitted disease (STD) testing. Sample size calculation was based on a three
month HIV patient population of 10,000 (hospital records), a 95% confidence level and 3.3
confidence interval, resulting in an estimated required sample size of 811. Among 813
eligible individuals recruited, three declined to participate, leaving a final sample of 810.
Participants completed a self-administered survey covering sociodemographics, health
behaviors and ART. Survey items were based on prior validated tools among HIV patients
(Bunnell et al., 2006; Eisele et al., 2009). The questionnaire was field-tested and revised
with input from Chinese clinic patients, six clinic physicians and three nurses. Participants
provided 2 ml of blood for syphilis testing and 5 ml of urine for gonorrhea and chlamydia
testing (see X.B. Wang et al., 2012 for laboratory procedures). Data on ART initiation and
recent CD4 count were abstracted from chart reviews. Institutional review boards from the
study hospital, Guangdong Provincial STD Control Center, and the University of North
Carolina at Chapel Hill approved the study. Participants provided informed consent and
received a small gift ($4 USD equivalent) as remuneration.
ANALYSIS
Two outcomes were assessed: recent non-adherence (missing any days of ART in the past
four weeks), and treatment interruption (missing four weeks or more of ART during the past
year). Univariate and multivariate associations with each adherence outcome were
calculated using logistic regression. A backward elimination process was used to build
multivariate models, and a p-value of <0.10 was required for retention in the final model.
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Collinearity was assessed using the variance inflation factor. SAS 9.2 (SAS Institute Inc.,
Cary NC, USA) was used to perform all data analysis.
RESULTS
89% of enrolled participants (721 out of 810) had started ART (Table 1). Participants taking
ART ranged in age from 19 to 79 years old, 61.3% were male, 67.5% had education of
middle school or lower, under a third were full-time employed, and 40.8% lived alone.
Average length of ART was 827 days, but 34.4% had been on ART under one year. Median
most recent CD4 count was 282 cells/μL. 89.5% of participants reported receiving sexual
risk reduction counseling at the start of ART. 17% of participants had not used a condom at
last intercourse, and prevalence of any STD was 9.3%. Overall, 20.6% (n=147) of
participants reported drinking alcohol in the past month. Among these 79.6% (n=117) drank
alcohol several times a month (moderate), while 20.4% (n=30) drank alcohol several times a
week or more (heavy).
Recent non-adherence
18.9% (n=136) of participants reported recent non-adherence (Table 2). In the multivariate
analysis, lower education, living alone, alcohol use and longer time on ART were associated
with recent non-adherence. Lower education was associated with higher likelihood of recent
non-adherence as compared to those with some post-secondary education (high school:
adjusted odds ratio [aOR] 3.39; 95% confidence interval [CI], 1.32-8.71; middle school:
aOR 3.31, 95% CI, 1.36-8.07; primary school: aOR 4.52, 95% CI 1.78-11.45). Those who
lived alone were 1.49 times more likely to report recent non-adherence (95% CI, 1.00-2.21).
Alcohol use was associated with recent non-adherence for both moderate (aOR 3.76, 95%
CI, 1.65-8.55) and heavy (aOR 2.31, 95% CI, 1.44-3.71) consumption. Compared to patients
on therapy for less than one year, those on ART for one to three years were more likely to
report recent non-adherence (aOR 1.76, 95% CI, 1.10-2.84). This difference was not
significant among participants who had been on ART over three years compared to those on
therapy for under one year (aOR 1.26, 95% CI, 0.75-2.12).
Treatment interruption
6.8% (n=49) of participants reported treatment interruption in the past year (Table 3). In the
multivariate analysis, being male, having lower education, and longer time on ART were
associated with greater likelihood of treatment interruption. Men were 2.06 times more
likely to report treatment interruption that women (95% CI, 1.07-3.96). Education below
high school (middle school: aOR 6.55, 95% CI, 0.87-49.64; primary school aOR 14.31, 95%
CI, 1.86-110.27) was associated with higher likelihood of treatment interruption. There was
a non-significant trend between time on ART and treatment interruption. Participants who
had been on ART for one to three years were 1.91 times more likely to report a treatment
interruption compared to those who had been on therapy under one year (95% CI,
0.91-4.01).
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Among 721 ART-experienced patients in Guangzhou, China we found frequent ART non-
adherence and treatment interruptions. Recent non-adherence (18.9%) surpassed the median
rate found in a 6-country study (13.3%) (Corless et al., 2012) and rates reported in
comparable China-based samples (Corless et al., 2012; L. Li, Ji, Ding, Tian, & Lee, 2012;
Sabin et al., 2010; Simoni et al., 2011).
We found a relationship between alcohol use and adherence consistent with the global
literature (Azar, Springer, Meyer, & Altice, 2010; Braithwaite & Bryant, 2010) but not
identified in earlier Chinese studies (H. Wang et al., 2008; X. Wang & Wu, 2007).
Occasional, daily and binge drinking are significantly associated with worse adherence and
decreased survival worldwide (Braithwaite et al., 2005; Hendershot, Stoner, Pantalone, &
Simoni, 2009) – a serious concern given the portion of our participants who reported alcohol
use in the past month (20.6%). China has high levels of binge drinking and alcohol use
(Yang et al., 2012), yet prior adherence studies were not adequately powered to examine this
relationship. Alcohol use is also associated with high-risk sexual behaviors internationally
(Shuper, Joharchi, Irving, & Rehm, 2009) and in China (Q. Li, Li, & Stanton, 2010). Given
the 9.3% prevalence of STDs found in our sample, addressing alcohol use among HIV-
infected individuals could also improve prevention of STDs and forward HIV transmission.
Participants with lower education had worse ART adherence. Lower education is
consistently associated with lower HIV medication adherence across geographic and
economic settings (Fogarty et al., 2002; Rachlis, Mills, & Cole, 2011). This relationship is
not well-quantified in China though qualitative studies have explored complex economic,
employment and education-based barriers to adherence (L. Li et al., 2012; Sabin et al., 2008;
Starks et al., 2008). HIV-infected men were more likely than women to report treatment
interruptions. This differs from the global literature (Ammassari et al., 2002), but is
consistent with Chinese national data (Dou et al., 2011; Zhang et al., 2009) and may be even
more pronounced in rural areas (L. Li et al., 2012).
This study has several limitations. First, all recruitment took place in one outpatient setting.
This focused recruitment is a result of the centralized HIV care system in Guangzhou.
However, our sample has similar sociodemographic and HIV-transmission characteristics as
national samples of HIV-infected individuals on ART (Dou et al., 2011; Sabin et al., 2010;
Simoni et al., 2011; Zhang et al., 2009). Secondly, we lacked patient profile data on certain
factors found to be associated with non-adherence in previous studies, such as medication
tolerance, mental health status, and social support (L. Li et al., 2012; Sabin et al., 2008;
Starks et al., 2008). As a possible proxy for social support, our finding that participants who
lived alone were more likely to report recent non-adherence suggests that more nuanced
measures of social support should be included in future adherence studies in China.
Numerous behavioral, pharmacologic and technology-based interventions to improve
adherence demonstrate that high levels of patient adherence are difficult to achieve and
maintain over time (Bae, Guyer, Grimm, & Altice, 2011; Mills et al., 2006). As ART
adherence interventions are being adapted and tested among Chinese patient populations
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(e.g. electronic drug monitoring (Sabin et al., 2010), nurse-delivered (Simoni et al., 2011),
cognitive behavioral therapy (Shiu et al., 2013)), we urge greater attention to developing
individualized, long-term medication adherence plans that are sensitive to patient
educational and economic factors, consider possible gender disparities in treatment
outcomes, and address alcohol use. Such plans should also address medication persistence
for ART-experienced patients, emphasizing the importance of continued treatment support
beyond the first year of therapy. These strategic adherence intervention components could
support expanded ART for improved clinical outcomes and reduced forward HIV
transmission.
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Table 1
Demographic and clinical characteristics of 721 HIV-infected patients on antiretroviral
therapy in Guangzhou, China
Characteristic n (%)
Age
  ≤ 30 years 127 (17.6)
  31 to 40 years 295 (40.9)
  41 to 60 years 259 (35.9)
  ≥ 61 years 40 (5.6)
Sex
  Male 442 (61.3)
  Female 279 (38.7)
Residence
  Guangzhou 269 (37.8)
  Other, Guangdong Province 443 (62.2)
Education
  ≤ Primary school 153 (21.2)
  Middle school 334 (46.3)
  High school 144 (20.0)
  Vocational school 56 (7.8)
  ≥ College 34 (4.7)
Employment
  Full-time 223 (31.1)
  Part-time or temporary 180 (25.1)
  Retired 43 (6.0)
  No employment 271 (37.8)
Marital status
  Single, live alone 127 (17.6)
  Cohabitating/married 451 (62.6)
  Separated/divorced 80 (11.1)
  Widowed 62 (8.6)
Alcohol
  Several times a week 30 (4.2)
  Several times a month 117 (16.4)
  Do not drink 567 (79.4)
Intravenous drug use in the past month
  Yes 26 (3.9)
  No 638 (96.1)
Most recent sex partner, last three months
  Casual partner 22 (2.7)
  Steady partner 328 (80.4)
  No partner 69 (16.9)






















Muessig et al. Page 9
Characteristic n (%)
Condoms at last intercourse
  Yes 343 (83.1)
  No 70 (17.0)
HIV transmission route
  Homosexual sex 70 (9.7)
  Heterosexual sex 272 (37.8)
  Intravenous drug use 138 (19.2)
  Transfusion 81 (11.3)
  Not sure/other 158 (22.0)
Received risk reduction counseling at ART initiation
  Yes 638 (89.5)
  No 75 (10.5)
Most recent CD4 count
  ≤ 200 cells/mm3 216 (30.0)
  ≥ 200 cells/mm3 505 (70.0)
Time on ART
  < 1 year 248 (34.4)
  1 to 3 years 270 (37.5)
  > 3 years 203 (28.2)
Tested positive, any STD
  Yes 67 (9.3)
  No 654 (90.7)
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